Company Filing History:
Years Active: 2016-2023
Title: Dohan Weeraratne: Innovator in Monoclonal Antibodies
Introduction
Dohan Weeraratne is a notable inventor based in Ventura, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 4 patents to his name, Weeraratne's work focuses on innovative solutions for treating headache conditions.
Latest Patents
One of his latest patents is titled "PACAP antibodies and uses thereof." This invention relates to monoclonal antibodies that specifically bind to human pituitary adenylate cyclase activating polypeptide (PACAP). The patent also describes pharmaceutical compositions comprising such antibodies. Furthermore, it outlines methods for treating or preventing headache conditions, such as migraine and cluster headache, using these monoclonal antibodies.
Career Highlights
Dohan Weeraratne is currently associated with Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to focus on groundbreaking research and development in the field of therapeutic antibodies. His contributions have been instrumental in advancing medical treatments for various conditions.
Collaborations
Throughout his career, Weeraratne has collaborated with esteemed colleagues, including Agnes Eva Hamburger and Cen Xu. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Dohan Weeraratne's work in the field of monoclonal antibodies represents a significant advancement in medical science. His innovative patents and collaborations continue to pave the way for new treatments for headache conditions.